Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular biomarkers in idiopathic pulmonary fibrosis.

American journal of physiology. Lung cellular and molecular physiology - 1 Nov 2014

Ley Brett, Brown Kevin K, Collard Harold R

Abstract excerpt

Molecular biomarkers are highly desired in idiopathic pulmonary fibrosis (IPF), where they hold the potential to elucidate underlying disease mechanisms, accelerated drug development, and advance clinical management. Currently, there are no molecular biomarkers in widespread clinical use for IPF, and the search for potential markers remains in its infancy. Proposed core mechanisms in the pathogenesis of IPF for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Proteins
Share to Idiopathic Pulmonary Fibrosis
Share to Mucin-5B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pulmonary Surfactant-Associated Proteins

Share to Respiratory Mucosa

Share to T-Lymphocytes, Regulatory

Share to Telomerase

Share to Toll-Like Receptor 3

Source

Open in PubMed Open full text

Identifiers

PMID: 25260757
DOI: 10.1152/ajplung.00014.2014
PMCID: PMC4280147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular biomarkers in idiopathic pulmonary fibrosis.PMID 25260757Read ↗

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?Semantic proximity Read ↗

PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.Semantic proximity Read ↗

Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype.Semantic proximity Read ↗

Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosisSemantic proximity Read ↗

Recent advances in understanding idiopathic pulmonary fibrosisSemantic proximity Read ↗

Identifying new molecular signatures and potential therapeutics for idiopathic pulmonary fibrosis: a network medicine approachSemantic proximity Read ↗

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Emerging cellular and molecular determinants of idiopathic pulmonary fibrosisSemantic proximity Read ↗

A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.Semantic proximity Read ↗

Identification of MDK as a diagnostic biomarker for idiopathic pulmonary fibrosis and its association with immune cell infiltrationSemantic proximity Read ↗

Interstitial lung diseases--where we started from and are now going.Semantic proximity Read ↗

Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.